Intuitive Surgical, Inc. Q3 2026 Earnings Recap

Intuitive’s shares fell 2.3% after earnings, a roughly flat reaction that suggests a measured response to the quarter rather than a clear market verdict. Procedure growth and system placements were solid, while the company’s new pricing actions for some high-volume benign procedures are expected to affect financial results.

Key Takeaways

• Total procedures grew 15% year over year: da Vinci procedures increased 14% and Ion procedures 31%. Da Vinci growth was 10% in the U.S. and 20% outside the U.S.
• Da Vinci system placements rose 28% worldwide; da Vinci 5 and SP accounted for 65% of placements. The installed base of da Vinci and Ion systems exceeded 13,200.
• More than 2,000 da Vinci 5 systems were installed worldwide, and over 18,000 surgeons have used the platform since launch.
• International da Vinci placements increased 29%. India’s procedures grew 42%, while the company said China’s operating environment remains challenging.
• Intuitive finalized pricing actions for a subset of high-volume benign procedures, aiming to broaden access. Management said the anticipated financial impact would be discussed later on the call.